Hubungan High Density Lipoprotein dengan Fatty Liver pada Mahasiswa Fakultas Kedokteran Universitas Muslim Indonesia yang Mengalami Obesitas
The Relationship Between High-Density Lipoprotein and Fatty Liver in Students of the Faculty of Medicine, Muslim University of Indonesia Who Experience Obesity
Abstract
Fatty liver atau Non-Alcoholic Fatty Liver Disease (NAFLD) merupakan salah satu manifestasi gangguan metabolik yang sering ditemukan pada individu obesitas. Kadar High Density Lipoprotein (HDL) yang rendah diketahui berhubungan dengan gangguan metabolisme lipid dan berpotensi meningkatkan risiko terjadinya perlemakan hati. Mengetahui hubungan kadar High Density Lipoprotein (HDL) dengan kejadian fatty liver pada mahasiswa Fakultas Kedokteran Universitas Muslim Indonesia yang mengalami obesitas. Penelitian ini menggunakan desain analitik observasional dengan pendekatan cross-sectional. Sampel penelitian berjumlah 33 mahasiswa obesitas yang dipilih menggunakan teknik purposive sampling. Kadar HDL diperiksa melalui pemeriksaan laboratorium darah, sedangkan status fatty liver ditentukan melalui pemeriksaan ultrasonografi (USG) hati. Analisis hubungan dilakukan menggunakan uji Chi-Square dengan tingkat signifikansi p<0,05. Sebagian besar responden berjenis kelamin laki-laki (60,6%), berada pada kategori obesitas II (54,5%), dan memiliki kadar HDL rendah (48,5%). Kejadian fatty liver ditemukan pada 11 responden (33,3%). Analisis bivariat menunjukkan adanya hubungan yang signifikan antara kadar HDL dengan kejadian fatty liver (p=0,022). Responden dengan kadar HDL rendah memiliki proporsi fatty liver lebih tinggi (56,3%) dibandingkan responden dengan HDL normal (15,4%), sedangkan tidak ditemukan kasus fatty liver pada responden dengan HDL tinggi. Terdapat hubungan yang signifikan antara kadar HDL dengan kejadian fatty liver pada mahasiswa Fakultas Kedokteran Universitas Muslim Indonesia yang mengalami obesitas. Kadar HDL yang rendah berhubungan dengan peningkatan risiko terjadinya fatty liver.
ABSTRACT
Fatty liver, or Non-Alcoholic Fatty Liver Disease (NAFLD), is a metabolic disorder commonly observed among individuals with obesity. Reduced High-Density Lipoprotein (HDL) levels are linked to disturbances in lipid metabolism and may contribute to a higher risk of developing fatty liver. This study aimed to analyze the relationship between HDL levels and the occurrence of fatty liver among obese students at the Faculty of Medicine, Muslim University of Indonesia. An observational analytic study with a cross-sectional design was conducted. A total of 33 obese students were selected using purposive sampling. HDL levels were measured through blood laboratory examinations, while fatty liver status was assessed using abdominal ultrasound (USG). The association between variables was analyzed using the Chi-Square test with a significance level of p < 0.05. The majority of participants were male (60.6%), classified as obesity class II (54.5%), and had low HDL levels (48.5%). Fatty liver was identified in 11 respondents (33.3%). Bivariate analysis indicated a significant relationship between HDL levels and fatty liver disease (p = 0.022). Individuals with low HDL levels showed a higher proportion of fatty liver (56.3%) compared to those with normal HDL levels (15.4%), while no cases were observed among participants with high HDL levels. The findings demonstrate a significant association between HDL levels and fatty liver in obese medical students at the Faculty of Medicine, Muslim University of Indonesia, indicating that lower HDL levels are related to an increased risk of fatty liver disease
References
Adolph, R. (2016). No title. Published online, 1–23.
Almira, I. D., & Nafianti, S. (2021). Hubungan pemberian kortikosteroid terhadap kenaikan berat badan pada anak penderita leukemia limfoblastik akut fase induksi di RSUP Haji Adam Malik Medan. Scripta Score Scientific Medical Journal, 2(2), 76–83. https://doi.org/10.32734/scripta.v2i2.3409
Amalia, M., Hidayati, P. H., Eka Yanti, A. K., Vitayani, S., & Gayatri, S. W. (2023). Karakteristik pasien sirosis hepatis. UMI Medical Journal, 8(1), 53–61. https://doi.org/10.33096/umj.v8i1.244
Ambulge, S., Bondre, T. A., Vyas, D., & Kishore, K. (2024). Etiology of non-alcoholic fatty liver disease. Systematic Review Article, 14(10), 75–80.
Busebee, B., Ghusn, W., Cifuentes, L., & Acosta, A. (2023). Obesity: A review of pathophysiology and classification. Mayo Clinic Proceedings, 98(12), 1842–1857. https://doi.org/10.1016/j.mayocp.2023.05.026
Cass, W. A. (n.d.). Atlas anatomi manusia organ dalam.
Erizon, E., & Karani, Y. (2020). HDL dan aterosklerosis. Human Care Journal, 5(4), 1123. https://doi.org/10.32883/hcj.v5i4.851
Grander, C., Grabherr, F., & Tilg, H. (2023). Non-alcoholic fatty liver disease: Pathophysiological concepts and treatment options. Cardiovascular Research, 119(9), 1787–1798. https://doi.org/10.1093/cvr/cvad095
Habibullah, M., Jemmieh, K., Ouda, A., Haider, M. Z., Malki, M. I., & Elzouki, A. N. (2024). Metabolic-associated fatty liver disease: A selective review of pathogenesis, diagnostic approaches, and therapeutic strategies. Frontiers in Medicine. https://doi.org/10.3389/fmed.2024.1291501
Hastuti, P. (2022). Obesity and the role of genetic polymorphism: A review of genes as the risk of obesity. Journal of Medical Sciences (Berkala Ilmu Kedokteran), 54(2), 181–201. https://doi.org/10.19106/jmedsci005402202209
Hendrianingtyas, M. (2022). Correlation of triglyceride/HDL-cholesterol ratio and visceral adiposity index with 25(OH)D in obese female. 29(1), 59–63.
In, C., Rattus, M., & With, N. (2025). Indonesian Journal of Global Health Research. 7(6), 27–34.
Le, M. H., Yeo, Y. H., Li, X., et al. (2022). 2019 global NAFLD prevalence: A systematic review and meta-analysis. Clinical Gastroenterology and Hepatology, 20(12), 2809–2817.e28. https://doi.org/10.1016/j.cgh.2021.12.002
Li, W., Ng, C. H., Quek, J., et al. (2022). The growing prevalence of nonalcoholic fatty liver disease (NAFLD), determined by fatty liver index, amongst young adults in the United States: A 20-year experience. https://doi.org/10.20517/mtod.2022.24
Lorensia, A., Wongkar, L. W., & Suryadinata, R. V. (2024). Association of high-density lipoprotein profile with cardiovascular risk factors in metabolic syndrome patients. 8, 1–5.
Muhamad, N. A., Maamor, N. H., & Leman, F. N. (2023). The global prevalence of nonalcoholic fatty liver disease and its association with cancers: Systematic review. 12, 1–13. https://doi.org/10.2196/40653
Pouwels, S., Sakran, N., Graham, Y., et al. (2022). Non-alcoholic fatty liver disease (NAFLD): A review of pathophysiology, clinical management and effects of weight loss. BMC Endocrine Disorders, 22(1), 1–10. https://doi.org/10.1186/s12902-022-00980-1
Ramadhany, R. A., Wahyuningsih, U., Sufyan, D. L., & Simanungkalit, S. F. (2023). Determinan gizi lebih dan obesitas pada remaja usia 13–15 tahun di DKI Jakarta (Analisis data Riskesdas 2018). Amerta Nutrition, 7(2SP), 124–131. https://doi.org/10.20473/amnt.v7i2sp.2023.124-131
Rasyid, M. F. A. (2021). Pengaruh asupan kalsium terhadap indeks masa tubuh (IMT). Jurnal Medika Hutama, 2(4), 1094–1097.
Savari, F., & Ali, S. (2024). Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment. Heliyon, 10(7), e28468. https://doi.org/10.1016/j.heliyon.2024.e28468
Sriwaningsi, L., Natadidjaja, H., Sudarma, V., & Herwana, E. (2023). Hubungan obesitas dan hipertrigliseridemia dengan kejadian perlemakan hati pada usia 30–60 tahun. Jurnal Kesehatan Tambusai, 4(3), 2745–2755.
Surgery, B. (2024). Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024. Obesity Pillars, 10. https://doi.org/10.1016/j.obpill.2024.100108
Suryadinata, R. V., & Sukarno, D. A. (2019). The effect of physical activity on the risk of obesity in adulthood. Indonesian Journal of Public Health, 14(1), 104–114. https://doi.org/10.20473/ijph.v14i1.2019.104-114
Tchang, B. G., Saunders, K. H., & Igel, L. I. (2021). Best practices in the management of overweight and obesity. Medical Clinics of North America, 105(1), 149–174. https://doi.org/10.1016/j.mcna.2020.08.018
Trieb, M., Horvath, A., Birner-Gruenberger, R., & Spindelboeck, W. (2017). Liver disease alters high-density lipoprotein composition, metabolism and function. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1861(7), 630–638. https://doi.org/10.1016/j.bbalip.2016.04.013
William, Adnan, S., Michelle, L., Heidi, B., Kethy, K., & Kristen, K. (2019). Non-alcoholic fatty liver disease: A patient’s guide (Vol. 2, pp. 1–15). https://www.hepatitis.va.gov/
Yao, Y. (2025). Association between obesity and non-alcoholic fatty liver disease (NAFLD) in adults aged 18 years and above. 32(4), 518–522. https://doi.org/10.26444/aaem/210489
